Gilead Sciences Announces Completion of Acquisition of CymaBayBusiness Wire • about 1 month agoGilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for approximately $4.3 billion in...